clinical trial · NCT05313308
A Survey of Midazolam in People With Status Epilepticus
Clinigen K.K.·—·recruiting·n = 50
EpilepsyMidazolam
brief summary
This study is a survey in Japan of midazolam oromucosal solution used to treat people with status epilepticus. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study. The main aim of the study is to check for side effects related from midazolam oromucosal solution and to check if midazolam oromucosal solution improves symptoms of status epilepticus. During the study, participants with status epilepticus will take midazolam oromucosal solution according to their clinic's standard practice. The study doctors will check for side effects from midazolam for 6 months.
started
Jun 1, 2021
primary completion
Aug 31, 2028
completion
Aug 31, 2028
last updated
May 18, 2026
official title
BUCCOLAM OROMUCOSAL SOLUTION - Special Drug Use Surveillance
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol